$SNGX
Soligenix, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Princeton, NJ
SNGX chart
What traders are saying about $SNGX
Latest postsSoligenix, Inc. news
- Form 4 Soligenix Inc For: 7 November By Investing.com
Investing.com Canada ·
- Soligenix Stock Price Forecast. Should You Buy SNGX?
StockInvest.us ·
- Soligenix Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Soligenix 3Q 2026: Revenue $0, EPS ($0.05) — 10-Q Summary
TradingView ·
- Soligenix reports $1.1M Q3 loss, advances rare disease drug SGX945, cash to fund operations through Q2 2028
Pluang ·
- Soligenix Q3FY26 Results: Net loss narrows 56% YoY to $1.1 million
scanx.trade ·
- Soligenix, Inc. (SNGX) Tops Q3 EPS by 10c
StreetInsider ·
- Soligenix 3Q Research and Development Expenses $400,000 >SNGX
Moomoo ·
- Soligenix Announces Recent Updates and Third Quarter 2026 Financial Results
Yahoo Finance ·
- Soligenix, Inc. (SNGX) Q3 Net Loss Falls To $1.1M; Cash Is $9.0M
TradingView ·
- Soligenix, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (SNGX)
Traders Union ·
- Radiotherapy-Induced Oral Mucositis Market Set for Strong Growth Through 2036, Driven by Emerging Therapies and Rising Cancer Burden | DelveInsight
Yahoo Finance ·
Soligenix, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $119,371 | $839,359 | $948,911 |
| Net income | -$11.1M | -$8.3M | -$6.1M | -$13.8M |
| Diluted EPS | $-2.14 | $-4.98 | $-12.66 | $-4.81 |
| Total assets (year end) | $9.2M | $9.0M | $9.8M | $14.3M |
| Cash and equivalents (year end) | – | – | – | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Soligenix, Inc.
- Ticker
- SNGX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Princeton, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 812796
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP
Frequently asked questions
What exchange is Soligenix, Inc. listed on?
Soligenix, Inc. trades on the Nasdaq under the ticker symbol SNGX.
What industry is Soligenix, Inc. in?
Soligenix, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Soligenix, Inc. headquartered?
Soligenix, Inc.'s business address on file with the SEC is in Princeton, NJ.
When does Soligenix, Inc.'s fiscal year end?
Soligenix, Inc.'s fiscal year ends on December 31.
How much revenue did Soligenix, Inc. report?
Soligenix, Inc. reported $119,371 in revenue for calendar year 2024, according to its SEC filings.